+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Daiichi Sankyo Co Ltd - logo

Daiichi Sankyo is a global pharmaceutical company and one of the largest pharmaceutical company in Japan. The company offers therapies in the areas of hypertension, dyslipidemia, diabetes, acute coronary syndrome, metastatic melanoma, cardiology, oncology, pain, and others. Formerly known as Sankyo Pharma, it changed its name to Daiichi Sankyo in April 2006. The company was founded in 1996 and is based in Parsippany, New Jersey.

From
From
From
US Glioma - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

US Glioma - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • April 2023
  • 200 Pages
  • United States
From
Acute Myeloid Leukemia (AML) Treatment Market in APAC 2024-2028 - Product Thumbnail Image

Acute Myeloid Leukemia (AML) Treatment Market in APAC 2024-2028

  • Report
  • October 2024
  • 126 Pages
  • Asia Pacific
From
From
Industry Snapshots: Japan Pharmaceuticals - Product Thumbnail Image

Industry Snapshots: Japan Pharmaceuticals

  • Newsletter
  • November 2024
  • 75 Pages
  • Japan
From
Company Snapshots: Japan Pharmaceutical - Product Thumbnail Image

Company Snapshots: Japan Pharmaceutical

  • Newsletter
  • November 2024
  • 35 Pages
  • Japan
From
From
G-Protein Coupled Receptors Global Market Report 2024 - Product Thumbnail Image

G-Protein Coupled Receptors Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Type 2 Diabetes Global Market Report 2024 - Product Thumbnail Image

Type 2 Diabetes Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
From
From
From
From
Neurofibrosarcoma - Pipeline Insight, 2024 - Product Thumbnail Image

Neurofibrosarcoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 120 Pages
  • Global
From
Loading Indicator